The site will be unavailable from 11:00 PM GMT on Tuesday, 21 July 2026, until 4:00 AM GMT on Wednesday, 22 July 2026, due to scheduled maintenance.

zanidatamab

15th Aug 2024

Results from the phase 2b HERIZON-BTC-01 study of zanidatamab in HER2-amplified biliary tract cancer: a plain language summary